Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) is a publicly traded Healthcare sector company. As of October 22, 2026, KNSA trades at $80.76 with a market cap of $6.22B and a P/E ratio of 73.40. KNSA moved +1.34% today. Year to date, KNSA is +89.74%; over the trailing twelve months it is +105.15%. Its 52-week range spans $18.26 to $84.06. Analyst consensus is strong buy with an average price target of $96.57. Rallies surfaces KNSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest KNSA news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $80.76 |
| Market Cap | $6.22B |
| P/E Ratio | 73.40 |
| EPS | $1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $84.06 |
| 52-Week Low | $18.26 |
| Volume | 325.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $840.85M |
| Net Income | $80.66M |
| Gross Margin | 89.82% |
7 analysts cover KNSA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $96.57.